Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | STAT1 | P42224 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8692255 | 0.80 | STAT3 (0.43) | STAT3STAT1 | |
| SCHEMBL352669 | 0.79 | STAT3 (0.47) | STAT3STAT1 | |
| SCHEMBL461738 | 0.79 | STAT3 (0.47) | STAT3STAT1 | |
| SCHEMBL7261521 | 0.79 | STAT3 (0.42) | STAT3STAT1 | |
| SCHEMBL8177649 | 0.76 | STAT3 (0.50) | STAT3STAT1 | |
| SCHEMBL1345645 | 0.76 | STAT3 (0.49) | STAT3STAT1 | |
| Water SCHEMBL4929925 | 0.75 | STAT3 (0.58) | STAT3STAT1 | |
| SCHEMBL1595495 | 0.75 | STAT3 (0.44) | STAT3STAT1 | |
| SCHEMBL3447556 | 0.75 | STAT3 (0.44) | STAT3STAT1 | |
| SCHEMBL1595493 | 0.75 | STAT3 (0.44) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080280934-A1 | Method of Preparing Porphyrin Derivatives, Porphyrin Derivatives, Uses Thereof and Pharmaceutical Compositions | SPECTRACURE AB (SE) | 2008-11-13 | — | — | US | claimed |
| EP-1709048-A2 | METHOD OF PREPARING PORPHYRIN DERIVATIVES, PORPHYRIN DERIVATIVES, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS | Photobiochem N.V. (NL) | 2006-10-11 | — | — | EP | claimed |
| WO-2005058909-A2 | METHOD OF PREPARING PORPHYRIN DERIVATIVES, PORPHYRIN DERIVATIVES, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS | PHOTOBIOCHEM N.V. (NL) | 2005-06-30 | — | — | WO | claimed |
| US-20080280934-A1 | Method of Preparing Porphyrin Derivatives, Porphyrin Derivatives, Uses Thereof and Pharmaceutical Compositions | SPECTRACURE AB (SE) | 2008-11-13 | — | — | US | disclosed |
| EP-1709048-A2 | METHOD OF PREPARING PORPHYRIN DERIVATIVES, PORPHYRIN DERIVATIVES, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS | Photobiochem N.V. (NL) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005058909-A2 | METHOD OF PREPARING PORPHYRIN DERIVATIVES, PORPHYRIN DERIVATIVES, USES THEREOF AND PHARMACEUTICAL COMPOSITIONS | PHOTOBIOCHEM N.V. (NL) | 2005-06-30 | — | — | WO | disclosed |
| EP-0979104-B1 | SONODYNAMIC THERAPY USING AN ULTRASOUND SENSITIZER COMPOUND | AMERSHAM HEALTH AS (NO) | 2004-09-15 | — | — | EP | disclosed |
| US-6498945-B1 | FREE RADICAL GENERATION OF WATER SOLUBLE POLYMER TO ENHANCE CYTOPATHOGENIC EFFICACY | AMERSHAM HEALTH AS (NO) | 2002-12-24 | — | — | US | disclosed |
| EP-0979104-A1 | SONODYNAMIC THERAPY USING AN ULTRASOUND SENSITIZER COMPOUND | NYCOMED IMAGING A/S (NO) | 2000-02-16 | — | — | EP | disclosed |
| WO-1998052609-A1 | SONODYNAMIC THERAPY USING AN ULTRASOUND SENSITIZER COMPOUND | NYCOMED IMAGING AS (NO) | 1998-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280934-A1 | Method of Preparing Porphyrin Derivatives, Porphyrin Derivatives, Uses Thereof and Pharmaceutical Compositions | PANK2, PPOX, MVD | STAT3 1825/4885STAT1 1862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.